Carl Zeiss Meditec AG (CZMWY)
107.03
+1.78
(+1.69%)
USD |
OTCM |
May 01, 16:00
Carl Zeiss Meditec Price to Book Value: 4.188 for May 1, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 01, 2024 | 4.188 |
| April 30, 2024 | 4.118 |
| April 29, 2024 | 4.217 |
| April 26, 2024 | 4.20 |
| April 25, 2024 | 4.163 |
| April 24, 2024 | 4.212 |
| April 23, 2024 | 4.292 |
| April 22, 2024 | 4.117 |
| April 19, 2024 | 4.059 |
| April 18, 2024 | 4.042 |
| April 17, 2024 | 4.038 |
| April 16, 2024 | 4.238 |
| April 15, 2024 | 4.254 |
| April 12, 2024 | 4.242 |
| April 11, 2024 | 4.366 |
| April 10, 2024 | 4.420 |
| April 09, 2024 | 4.535 |
| April 08, 2024 | 4.537 |
| April 05, 2024 | 4.510 |
| April 04, 2024 | 4.612 |
| April 03, 2024 | 4.712 |
| April 02, 2024 | 4.845 |
| April 01, 2024 | 5.048 |
| March 28, 2024 | 4.894 |
| March 27, 2024 | 5.066 |
| Date | Value |
|---|---|
| March 26, 2024 | 5.028 |
| March 25, 2024 | 4.998 |
| March 22, 2024 | 5.016 |
| March 21, 2024 | 4.908 |
| March 20, 2024 | 5.016 |
| March 19, 2024 | 5.118 |
| March 18, 2024 | 5.102 |
| March 15, 2024 | 5.138 |
| March 14, 2024 | 5.219 |
| March 13, 2024 | 5.155 |
| March 12, 2024 | 5.180 |
| March 11, 2024 | 5.117 |
| March 08, 2024 | 5.124 |
| March 07, 2024 | 5.000 |
| March 06, 2024 | 4.984 |
| March 05, 2024 | 5.005 |
| March 04, 2024 | 4.984 |
| March 01, 2024 | 4.921 |
| February 29, 2024 | 4.822 |
| February 28, 2024 | 4.737 |
| February 27, 2024 | 4.745 |
| February 26, 2024 | 4.721 |
| February 23, 2024 | 4.801 |
| February 22, 2024 | 4.796 |
| February 21, 2024 | 4.652 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
3.042
Minimum
Oct 26 2023
11.63
Maximum
Sep 15 2021
6.528
Average
6.330
Median
Jun 03 2022
Price to Book Value Benchmarks
| Affimed NV | 1.270 |
| InflaRx NV | 0.7322 |
| MorphoSys AG | 48.72 |
| BioNTech SE | 0.9686 |
| Immatics NV | 4.474 |
Price to Book Value Related Metrics
| PE Ratio | 31.84 |
| PS Ratio | 4.215 |
| Price to Free Cash Flow | 59.04 |
| Price | 107.03 |
| Earnings Yield | 3.14% |
| Market Cap | 9.573B |
| Operating PE Ratio | 26.61 |
| Normalized PE Ratio | 31.84 |